344 related articles for article (PubMed ID: 12601282)
1. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
Miyazawa T; Matsumoto M; Kato S; Takeuchi K
Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
[TBL] [Abstract][Full Text] [Related]
2. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
3. Role of dietary fibres, intestinal hypermotility and leukotrienes in the pathogenesis of NSAID-induced small intestinal ulcers in cats.
Satoh H; Shiotani S; Otsuka N; Hatao K; Nishimura S
Gut; 2009 Dec; 58(12):1590-6. PubMed ID: 19060018
[TBL] [Abstract][Full Text] [Related]
4. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D₂-receptor antagonists ameliorate indomethacin-induced small intestinal ulceration in mice by activating α7 nicotinic acetylcholine receptors.
Yasuda M; Kawahara R; Hashimura H; Yamanaka N; Iimori M; Amagase K; Kato S; Takeuchi K
J Pharmacol Sci; 2011; 116(3):274-82. PubMed ID: 21691039
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
[TBL] [Abstract][Full Text] [Related]
7. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
8. Permissive role of neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats.
Suzuki K; Araki H; Komoike Y; Takeuchi K
Med Sci Monit; 2000; 6(5):908-14. PubMed ID: 11208431
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats.
Nishio H; Hayashi Y; Terashima S; Takeuchi K
Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018
[TBL] [Abstract][Full Text] [Related]
10. The effect of gastric cytoprotective drugs (atropine, cimetidine, vitamin-A) on the indomethacin induced intestinal ulcers in rats.
Beró T; Németh A; Mózsik G; Jávor T
Acta Physiol Hung; 1984; 64(3-4):343-7. PubMed ID: 6532122
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Nishijima M; Tanaka A; Kunikata T; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Mar; 50(1):25-38. PubMed ID: 10210152
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats.
Takeuchi K; Miyazawa T; Tanaka A; Kato S; Kunikata T
Digestion; 2002; 66(1):30-41. PubMed ID: 12379813
[TBL] [Abstract][Full Text] [Related]
14. Influence of Adrenalectomy on Protective Effects of Urocortin I, a Corticotropin-Releasing Factor, Against Indomethacin-Induced Enteropathy in Rats.
Takeuchi K; Abe N; Kumano A
Curr Neuropharmacol; 2016; 14(8):866-875. PubMed ID: 27397599
[TBL] [Abstract][Full Text] [Related]
15. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
Takeuchi K; Yokota A; Tanaka A; Takahira Y
Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
[TBL] [Abstract][Full Text] [Related]
16. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors.
Kunikata T; Tanaka A; Miyazawa T; Kato S; Takeuchi K
Dig Dis Sci; 2002 Apr; 47(4):894-904. PubMed ID: 11991626
[TBL] [Abstract][Full Text] [Related]
17. Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid.
Takeuchi K; Hase S; Mizoguchi H; Komoike Y; Tanaka A
J Physiol Paris; 2001; 95(1-6):51-7. PubMed ID: 11595418
[TBL] [Abstract][Full Text] [Related]
18. Exacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout mice.
Imaoka H; Ishihara S; Kazumori H; Kadowaki Y; Aziz MM; Rahman FB; Ose T; Fukuhara H; Takasawa S; Kinoshita Y
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G311-9. PubMed ID: 20508157
[TBL] [Abstract][Full Text] [Related]
19. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
Yin Y; Dong L; Yin D
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e79-87. PubMed ID: 17944898
[TBL] [Abstract][Full Text] [Related]
20. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.
Hayashi S; Kurata N; Yamaguchi A; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Jun; 349(3):470-9. PubMed ID: 24713141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]